Skip to main content

Table 2 Clinicopathological characteristics of 118 patients who underwent robotic-assisted pancreatic resection

From: Robotic-assisted pancreatic surgery in the elderly patient: experiences from a high-volume centre

Characteristics

Group 1 ≥ 70 years (n = 32)

Group 2 < 70 years (n = 86)

P

Sex, n (%)

  

0.142a

 Female

19 (59)

38 (44)

 

 Male

13 (41)

48 (56)

 

Median age at resection, years (range)

75.5 (70–87)

55.5 (22–69)

 < 0.0001b

Median BMI, kg/m2 (range)

24.6 (18.0–35.4)

25.4 (18.5–41.9)

0.066b

BMI ≥ 30 kg/m2, n (%)

2 (6)

15 (17)

0.152a

Comorbidities, n (%)

   

 Cardiovascular disease

24 (75)

44 (51)

0.020a

 Diabetes

6 (19)

9 (11)

0.231a

 Pulmonary disease

2 (6)

13 (15)

0.350a

 Renal insufficiency

1 (3)

1 (1)

0.471a

ASA physical status, n (%)

  

0.415a

 I

0 (0)

4 (5)

 

 II

20 (63)

55 (64)

 

 III

12 (37)

27 (31)

 

Malignant diagnosis, n (%)

21 (66)

47 (55)

0.284a

Diagnosis, n (%)

  

0.630a

 Insulinoma

0 (0)

3 (4)

 

 Neuroendocrine tumor

1 (3)

5 (6)

 

 IPMN

7 (22)

13 (15)

 

 Pancreatitis

1 (3)

13 (15)

 

 MCN

1 (3)

2 (2)

 

 SCN

1 (3)

4 (5)

 

 SPN

0 (0)

2 (2)

 

 PDAC

12 (38)

26 (30)

 

 Periampullary carcinoma

7 (22)

12 (14)

 

 Intrapancreatic metastases

1 (3)

1 (1)

 

 Others

1 (3)

5 (6)

 

Previous abdominal surgery, n (%)

25 (78)

32 (37)

 < 0.0001a

  1. Bold values are statistically significant
  2. BMI, body mass index; ASA, American Society of Anesthesiologists; IPMN, Intraductal papillary mucinous neoplasm; MCN, Mucinous cystic neoplasm; SCN, Serous cystic neoplasm; SPN, Solid-pseudopapillary neoplasm; PDAC, Pancreatic ductal adenocarcinoma
  3. aChi-Square or Fisher`s Exact Test
  4. bMann Whitney Test